Focused on RNA-targeted drug development, this biotechnology company develops antisense therapies designed to treat rare and serious diseases by altering the production of disease-causing proteins. Its business model combines an internal clinical pipeline with licensing partnerships that generate mi...
6 members of Congress have disclosed 12 trades in Ionis Pharmaceuticals, Inc. (IONS), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 4 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-09-13 | Rohit Khanna | buy | $1K – $15K |
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |
| 2019-06-24 | Donna Shalala | sell | $1K – $15K |
| 2019-05-08 | Donna Shalala | buy | $1K – $15K |
| 2018-11-05 | JAMES B. RENACCI | buy | $1K – $15K |
| 2016-11-02 | Thomas MacArthur | buy | $1K – $15K |
| 2016-11-02 | Thomas MacArthur | buy | $15K – $50K |
| 2016-11-02 | Thomas MacArthur | buy | $1K – $15K |
| 2016-02-24 | Thomas MacArthur | buy | $1K – $15K |
| 2016-02-12 | Thomas MacArthur | buy | $1K – $15K |
| 2016-02-02 | Thomas MacArthur | sell | $15K – $50K |
| 2016-01-20 | Sheldon Whitehouse | sell | $1K – $15K |